Université Clermont Auvergne, INRAE, UNH, Clermont-Ferrand, France.
Université Paris-Saclay, INRAE UMR1319, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1460-1476. doi: 10.1002/jcsm.12964. Epub 2022 Mar 12.
Evidence suggests that gut microbiota composition and diversity can be a determinant of skeletal muscle metabolism and functionality. This is true in catabolic (sarcopenia and cachexia) or anabolic (exercise or in athletes) situations. As gut microbiota is known to be causal in the development and worsening of metabolic dysregulation phenotypes such as obesity or insulin resistance, it can regulate, at least partially, skeletal muscle mass and function. Skeletal muscles are physiologically far from the gut. Signals generated by the gut due to its interaction with the gut microbiome (microbial metabolites, gut peptides, lipopolysaccharides, and interleukins) constitute links between gut microbiota activity and skeletal muscle and regulate muscle functionality via modulation of systemic/tissue inflammation as well as insulin sensitivity. The probiotics able to limit sarcopenia and cachexia or promote health performances in rodents are mainly lactic acid bacteria and bifidobacteria. In humans, the same bacteria have been tested, but the scarcity of the studies, the variability of the populations, and the difficulty to measure accurately and with high reproducibility muscle mass and function have not allowed to highlight specific strains able to optimize muscle mass and function. Further studies are required on more defined population, in order to design personalized nutrition. For elderly, testing the efficiency of probiotics according to the degree of frailty, nutritional state, or degree of sarcopenia before supplementation is essential. For exercise, selection of probiotics capable to be efficient in recreational and/or elite athletes, resistance, and/or endurance exercise would also require further attention. Ultimately, a combination of strategies capable to optimize muscle functionality, including bacteria (new microbes, bacterial ecosystems, or mix, more prone to colonize a specific gut ecosystem) associated with prebiotics and other 'traditional' supplements known to stimulate muscle anabolism (e.g. proteins), could be the best way to preserve muscle functionality in healthy individuals at all ages or patients.
有证据表明,肠道微生物群落组成和多样性可能是骨骼肌肉代谢和功能的决定因素。无论是在分解代谢(如肌肉减少症和恶病质)还是合成代谢(如运动或运动员)情况下都是如此。由于肠道微生物群在代谢失调表型(如肥胖或胰岛素抵抗)的发展和恶化中起因果关系,它可以至少部分调节骨骼肌质量和功能。骨骼肌在生理上与肠道相去甚远。由于肠道与肠道微生物群相互作用而产生的信号(微生物代谢物、肠道肽、脂多糖和白细胞介素)构成了肠道微生物群活性与骨骼肌之间的联系,并通过调节全身/组织炎症以及胰岛素敏感性来调节肌肉功能。能够限制啮齿动物肌肉减少症和恶病质或促进健康表现的益生菌主要是乳酸菌和双歧杆菌。在人类中,已经测试了相同的细菌,但由于研究的稀缺性、人群的可变性以及难以准确和高度重现性地测量肌肉质量和功能,因此尚未能够突出能够优化肌肉质量和功能的特定菌株。需要在更明确的人群中进行进一步的研究,以设计个性化营养。对于老年人,在补充前根据虚弱程度、营养状况或肌肉减少症程度测试益生菌的效率至关重要。对于运动,选择能够在娱乐和/或精英运动员、阻力和/或耐力运动中有效的益生菌也需要进一步关注。最终,包括细菌(更容易定植特定肠道生态系统的新微生物、细菌生态系统或混合物)与益生元及其他已知刺激肌肉合成代谢的“传统”补充剂(例如蛋白质)相结合的策略,可能是在所有年龄段的健康个体或患者中保持肌肉功能的最佳方式。